Skip to content
PoliticalRepoPoliticalRepo

Person

Official portrait of Sen. Schmitt, Eric [R-MO]

Sen. Schmitt, Eric [R-MO]

United States · Official source

Records

517 records where Sen. Schmitt, Eric [R-MO] is listed as a sponsor, author, or other actor. Search with topics and years

Bill· SS. 3456 (119th)open

Law Enforcement Officer and Firefighter Recreation Pass Act

United States · United States Congress · 11 December 2025

Law Enforcement Officer and Firefighter Recreation Pass Act This bill directs the Forest Service and the Department of the Interior to make the National Parks and Federal Recreational Lands Pass available, without charge, to law enforcement officers and firefighters.

Bill· SS. 3302 (119th)referred

Mikaela Naylon Give Kids a Chance Act of 2025

United States · United States Congress · 2 December 2025

Mikaela Naylon Give Kids a Chance Act of 2025 This bill authorizes certain targeted clinical trials involving combinations of drugs to treat pediatric cancer, and renews the Food and Drug Administration’s (FDA’s) authority to award priority review vouchers (PRVs) to sponsors of new products for rare pediatric diseases. Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs used in combination with active ingredients that have already been approved and that (1) have been determined to be part of the standard of care for treating a pediatric cancer, or (2) have been approved to treat an adult cancer and are directed at molecular targets for pediatric cancer. The FDA must issue guidance on the implementation of these provisions and report to Congress on its efforts to ensure implementation. The Government Accountability Office (GAO) must report on the effectiveness of the bill's changes with respect to the development of pediatric cancer drugs. The bill also renews the FDA’s authority to issue PRVs to sponsors of new products intended to treat rare pediatric diseases through September 30, 2030. This is known as the Rare Pediatric Disease PRV program. The program expired in December 2024. GAO must report on the effectiveness of the Rare Pediatric Disease PRV program, including to what extent PRVs were successful in promoting drug development and expediting patient access to drugs for the treatment or prevention of rare pediatric diseases.

Bill· SS. 3179 (119th)referred

Halo Act

United States · United States Congress · 18 November 2025

Bill· SS. 3080 (119th)referred

Nitazene Sanctions Act

United States · United States Congress · 30 October 2025

Bill· SS. 3076 (119th)referred

Nitazene Control Act

United States · United States Congress · 30 October 2025

Bill· SS. 3054 (119th)referred

Kayla Hamilton Act

United States · United States Congress · 23 October 2025

Bill· SS. 2873 (119th)referred

Undersea Cable Protection Act of 2025

United States · United States Congress · 18 September 2025

Undersea Cable Protection Act of 2025 This bill prohibits the Department of Commerce from enforcing certain permit requirements for activities related to undersea fiber optic cables in national marine sanctuaries.  Specifically, Commerce may not prohibit or require an authorization for any covered activities related to undersea fiber optic cables if a license, lease, or permit has been issued by a state or federal agency to authorize the covered activity. Covered activities are the installation, continued presence, operation, maintenance, repair, or recovery of undersea fiber optic cables in a national marine sanctuary. The bill also authorizes Commerce to direct the National Oceanic and Atmospheric Administration to engage in interagency cooperation regarding federal agency actions that are likely to destroy, cause the loss of, or injure a resource in a national marine sanctuary and involve covered activities.  

Bill· SS. 2907 (119th)referred

Chloe Cole Act

United States · United States Congress · 18 September 2025

Bill· SJRESS.J.Res. 79 (119th)referred

A joint resolution honoring the sacrifice of Marine Corps Lance Corporal David L. Espinoza, Marine Corps Sergeant Nicole L. Gee, Marine Corps Staff Sergeant Darin Taylor Hoover, Army Staff Sergeant Ryan Christian Knauss, Marine Corps Corporal Hunter Lopez, Marine Corps Lance Corporal Rylee J. McCollum, Marine Corps Lance Corporal Dylan R. Merola, Marine Corps Lance Corporal Kareem M. Nikoui, Marine Corps Corporal Daegan W. Page, Marine Corps Sergeant Johanny Rosario, Marine Corps Corporal Humberto A. Sanchez, Marine Corps Lance Corporal Jared M. Schmitz, and Navy Petty Officer Third Class Maxton W. Soviak.

United States · United States Congress · 17 September 2025

Bill· SS. 2841 (119th)open

CIVICS Act of 2025

United States · United States Congress · 17 September 2025

Resolution· SRESS.Res. 392 (119th)passed

A resolution expressing support for the designation of November 16, 2025, as "National Warrior Call Day" and recognizing the importance of connecting members of the Armed Forces and veterans in the United States to support structures necessary to transition from the battlefield, especially peer-to-peer connection.

United States · United States Congress · 16 September 2025

This resolution supports the designation of November 16, 2025, as National Warrior Call Day and encourages individuals to engage with warriors (i.e., members of the Armed Forces and veterans) to connect and provide support.

Bill· SS. 2764 (119th)referred

STUDENT Act

United States · United States Congress · 10 September 2025

Bill· SS. 2686 (119th)referred

DC CRIMES Act

United States · United States Congress · 2 September 2025

Bill· SS. 2687 (119th)referred

CLEAN DC Act

United States · United States Congress · 2 September 2025

Common-Sense Law Enforcement and Accountability Now in DC Act or the CLEAN DC Act This bill repeals the Comprehensive Policing and Justice Reform Amendment Act of 2022, enacted by the Council of the District of Columbia. Any provision of law amended or repealed by that act is restored or revived as if it had not been enacted. (The act sets forth a variety of measures that focus on policing, including measures prohibiting the use of certain neck restraints by law enforcement officers, requiring additional procedures related to body-worn cameras, and expanding access to police disciplinary records.)

Bill· SS. 2546 (119th)open

A bill to provide for an extension of the legislative authority of the National Emergency Medical Services Memorial Foundation to establish a commemorative work in the District of Columbia and its environs.

United States · United States Congress · 30 July 2025

This bill extends the authority of the National Emergency Medical Services Memorial Foundation to establish a commemorative work in the District of Columbia that honors the commitment and service of emergency medical services.

Bill· SS. 2503 (119th)failed

ROTOR Act

United States · United States Congress · 29 July 2025

Rotorcraft Operations Transparency and Oversight Reform Act or the ROTOR Act This bill addresses aviation safety by increasing requirements for aircraft tracking and communication using Automatic Dependent Surveillance-Broadcast (ADS-B) technology and expanding oversight. As background, ADS-B for broadcasting (Out) and receiving (In) transmits information (e.g., location and weather information) between aircraft and air traffic control. Under the bill, aircraft must generally operate with ADS-B In equipment to provide the aircraft with location information of other aircraft and traffic advisories. Current law does not require this equipment. Current Federal Aviation Administration (FAA) regulations allow aircraft performing a sensitive government mission to be excepted from requirements for using ADS-B Out equipment. This bill limits which flights may be considered sensitive government missions (e.g., not training flights) and requires additional reporting and notifications for the exception. The Government Accountability Office must review the use of the ADS-B Out exception and the Office of the Inspector General (OIG) of the Department of Transportation must annually audit FAA oversight of operations that use the exception. Further, the bill repeals a 2025 law that exempts certain military helicopters from the ADS-B Out requirements for the Washington, DC, metropolitan area. The bill also requires the OIG of the Army to audit the Army’s coordination with the FAA, the FAA to establish an office to coordinate airspace usage of military aircraft and review the safety of flight operations and routes around airports, and the FAA to enter into memoranda of understanding with military agencies for safety information sharing.

Bill· SS. 2308 (119th)open

PATRIOT Parks Act

United States · United States Congress · 16 July 2025

Bill· SS. 2278 (119th)referred

Graham Hoffman Act

United States · United States Congress · 15 July 2025

Bill· SS. 2269 (119th)referred

PRICE Act

United States · United States Congress · 14 July 2025

Bill· SS. 2067 (119th)open

Rescissions Act of 2025

United States · United States Congress · 12 June 2025

Rescissions Act of 2025 This bill rescinds specified unobligated funds that were provided to the Department of State, the U.S. Agency for International Development (USAID), various independent and related agencies, and the Corporation for Public Broadcasting.  The rescissions were proposed by the President under procedures included in the Congressional Budget and Impoundment Control Act of 1974. Under current law, the President may propose rescissions to Congress using specified procedures, and the rescissions must be enacted into law to take effect.  Specifically, the bill rescinds funds that were provided to the State Department or the President for Contributions to International Organizations; Contributions for International Peacekeeping Activities; Global Health Programs; Migration and Refugee Assistance; the Complex Crises Fund; the Democracy Fund; the Economic Support Fund; Contributions to the Clean Technology Fund; International Organization and Programs; Development Assistance; Assistance for Europe, Eurasia, and Central Asia; International Disaster Assistance; and Transition Initiatives. The bill also rescinds funds that were provided for  USAID Operating Expenses, the Inter-American Foundation, the U.S. African Development Foundation, the U.S. Institute of Peace, and the Corporation for Public Broadcasting.

Bill· SS. 2010 (119th)referred

TERMS Act

United States · United States Congress · 10 June 2025

Bill· SS. 2002 (119th)referred

REMIT Act

United States · United States Congress · 10 June 2025

Bill· SS. 1954 (119th)open

Biosimilar Red Tape Elimination Act

United States · United States Congress · 4 June 2025

Biosimilar Red Tape Elimination Act This bill deems all biosimilars licensed by the Food and Drug Administration (FDA) interchangeable with their reference products. A biosimilar is a biological product (e.g., a drug or vaccine) that is very similar to a brand-name biological product (i.e., the reference product). Under current law, a biosimilar that meets additional requirements may be deemed interchangeable with the reference product; this designation allows pharmacists to substitute the interchangeable biosimilar when filling a prescription for the reference product, depending on state law. Further, the first biosimilar deemed interchangeable with a given reference product is awarded a period of marketing exclusivity. The bill eliminates additional requirements for demonstrating interchangeability so that all licensed biosimilars are deemed interchangeable with their reference products. (Draft guidance released by the FDA in 2024 proposed to make some of these interchangeability requirements optional, including studies related to the safety of switching between use of the biosimilar and reference product. It has not been finalized.) This change takes effect 60 days after the bill is enacted, and previously licensed biosimilars must be deemed interchangeable with their reference products on that date. However, the bill preserves the exclusivity period for first interchangeable biosimilars licensed before the bill’s enactment. For example, if a new biosimilar licensed after the bill takes effect relies on the same reference product as an existing biosimilar that is subject to an unexpired exclusivity period, the new biosimilar is not deemed interchangeable with the reference product until the exclusivity period has ended.

Bill· SJRESS.J.Res. 56 (119th)referred

Life Month Resolution

United States · United States Congress · 3 June 2025